analyst
AC
NASDAQ · ACAD
ACADIA Pharmaceuticals Inc.
Healthcare · Biotechnology
$27.45
Down-$0.09 (-0.33%)
Updated Sep 18, 2026, 6:42 AM
SID Score
6.2/10
Composite research score
Smart Money
54/100
Neutral
- Market cap
- 4.16B
- P/E ratio
- 10.64
- Dividend yield
- 0.00%
- 52-week range
- $19.89 – $30.96
- Volume
- 1.31M
- Avg. volume
- 1.45M
Price performance
ACAD price history
1M range · 20 trading sessions · Daily adjusted prices
ACAD closed at $27.45 after 20 trading sessions, down 5.48% for the selected period.
- Last close
- $27.45
- Period change
- -5.48%
- Period low
- $26.76
- Period high
- $30.57
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 17, 2026 | $27.78 | $28.06 | $27.29 | $27.45 | 1.31M |
| Sep 16, 2026 | $26.75 | $27.60 | $26.66 | $27.54 | 1.41M |
| Sep 15, 2026 | $27.51 | $27.51 | $26.64 | $26.76 | 1.11M |
| Sep 14, 2026 | $27.995 | $28.10 | $27.3817 | $27.52 | 1.63M |
| Sep 11, 2026 | $27.98 | $28.24 | $27.74 | $27.83 | 1.17M |
| Sep 10, 2026 | $27.63 | $27.86 | $27.355 | $27.74 | 1.01M |
| Sep 9, 2026 | $27.44 | $27.95 | $27.40 | $27.68 | 1.29M |
| Sep 8, 2026 | $27.63 | $28.09 | $27.1001 | $27.58 | 1.46M |
| Sep 4, 2026 | $27.77 | $28.1942 | $27.65 | $28.02 | 1.68M |
| Sep 3, 2026 | $29.00 | $29.065 | $27.615 | $27.86 | 1.85M |
| Sep 2, 2026 | $29.10 | $29.75 | $28.875 | $28.93 | 1.56M |
| Sep 1, 2026 | $28.84 | $29.30 | $28.51 | $28.89 | 830.93K |
| Aug 31, 2026 | $29.05 | $29.12 | $28.575 | $28.91 | 1.04M |
| Aug 28, 2026 | $29.51 | $29.725 | $29.02 | $29.11 | 1.53M |
| Aug 27, 2026 | $29.26 | $29.83 | $29.15 | $29.73 | 879.37K |
| Aug 26, 2026 | $30.36 | $30.3799 | $29.28 | $29.58 | 1.34M |
| Aug 25, 2026 | $30.14 | $30.76 | $29.845 | $30.57 | 1.52M |
| Aug 24, 2026 | $29.50 | $29.775 | $29.15 | $29.65 | 1.49M |
| Aug 21, 2026 | $29.08 | $29.615 | $28.80 | $29.50 | 1.09M |
| Aug 20, 2026 | $30.00 | $30.00 | $28.95 | $29.04 | 1.32M |
Latest ACAD news
The latest Smart Investors Daily articles mentioning ACAD.
Stock researchCompany · Earnings
Loading stock research…